An interventional study of TMS and control group in Cataract Surgery Experience, sponsored by Shanghai High Myopia Study Group. Not yet recruiting at 1 site in China. Open to participants aged 30 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Shanghai High Myopia Study Group · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients after cataract surgery. The main question it aims to answer is:
Participants will
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's planned enrollment of 200 is above the median of 80 across 1,155 interventional studies indexed under Cataract.
Browse Cataract studies →Shanghai High Myopia Study Group is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
TMS treatment indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
Procedure: TMS
The sham group will be exposed to the recorded sounds of TMS pulses but without real magnetic stimulation.
Procedure: control group
TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
The control treatment is a sham-controlled procedure, in which participants will be exposed to the recorded sounds of TMS pulses but without real magnetic stimulation.
Visual acuity
Time frame: From enrollment to the end of treatment at 2 weeks
Visual field
Time frame: From enrollment to the end of treatment at 2 weeks
Visual quality
Include objective visual quality (contrast sensitivity) and subjective visual quality (visual function questionnaire score).
Time frame: From enrollment to the end of treatment at 12 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai High Myopia Study Group